Preliminary reports show conolidine may perhaps inhibit certain ion channels, cutting down neuronal excitability and limiting suffering alerts. This system is particularly appropriate in neuropathic soreness, in which irregular signaling will cause persistent pain. In addition, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to pain perception. https://emersont824nyw3.wikikarts.com/user